Medications

Existing drugs can prevent SARS-CoV-2 from hijacking cells

An international team of researchers has analyzed how SARS-CoV-2, the virus that causes COVID-19, hijacks the proteins in its target cells. The research, published in the journal Cell, shows how the virus shifts the cell's ...

Oncology & Cancer

Immune clues to help leukaemia patients safely stop treatment

Researchers with SAHMRI's Precision Medicine Theme have found a key to better identifying which chronic myeloid leukaemia (CML) patients can stop taking their medication and remain in treatment free remission (TFR).

Oncology & Cancer

New screening method identifies inhibitors of cancer cell metabolism

A new screening system developed by scientists at the UCLA Jonsson Comprehensive Cancer Center leverages redundancy in an important component of a cell—nucleotide metabolism—to help identify new drugs that specifically ...

Oncology & Cancer

Learning to stop cancer at its roots

Why do some cancers come back? Sometimes, a treatment can effectively eliminate cancer cells to undetectable levels, but, if the treatment stops, cancer may return. This is the case of chronic myeloid leukemia treated with ...

page 8 from 26